Skip to main content
. 2022 Mar 29;2022(3):CD012867. doi: 10.1002/14651858.CD012867.pub3

NCT04084938.

Study name Artery embolization vs operation of benign prostate hyperplasia (NORTAPE)
Methods Study design: parallel randomized controlled trial (open label)
Setting/country: single center/Norway
Participants Inclusion criteria: LUTS from BPH with moderate and severe IPSS score (IPSS > 8) and QoL ≥ 3; refractory to medical treatment for ≥ 6 months or the patient is unwilling to accept medical treatment; BPH using permanent or intermittent catheterization; prostate volume > 50 mL; signed informed consent
Interventions Group A: PAE
Group B: prostate operation through a catheter into the penis or through an incision in lower abdomen
Outcomes Primary outcome
  • QoL

  • Retreatment


Secondary outcomes
  • Postoperative complications

  • Hospital stay

  • IPSS

  • Need for catheters

  • Erectile function

  • Ejaculation

Starting date September 2019
Contact information fagreda.germanstrias@gencat.cat
Notes Sponsor: Oslo University Hospital